Bridgeway Capital Management »

Cytomx Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $966k 443k 2.18
2023-09-30 $480k 372k 1.29
2023-06-30 $409k 238k 1.72
2023-03-31 $266k 176k 1.51
2022-12-31 $282k 176k 1.60
2022-09-30 $255k 176k 1.45